<DOC>
	<DOC>NCT00240019</DOC>
	<brief_summary>The angiotensin converting enzyme inhibitor drugs are now standard therapy for patients with diabetic nephropathy. The hypothesis of this study is that adding a diuretic agent (furosemide) will decrease the urine protein, which is a sign of disease, more than an angiotensin converting enzyme inhibitor alone.</brief_summary>
	<brief_title>Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>proteinuria greater than 1 gram/day serum creatinine &lt; 2.6 for men, &lt; 2.0 for women blood pressure which cannot be controlled without a diuretic renal diseases other than diabetic nephropathy other disease which would alter renal function during 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>